Ralph H. Stern

2.0k total citations
39 papers, 1.6k citations indexed

About

Ralph H. Stern is a scholar working on Molecular Biology, Pharmacology and Surgery. According to data from OpenAlex, Ralph H. Stern has authored 39 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Pharmacology and 7 papers in Surgery. Recurrent topics in Ralph H. Stern's work include Pharmacogenetics and Drug Metabolism (7 papers), Lipoproteins and Cardiovascular Health (6 papers) and Drug Transport and Resistance Mechanisms (6 papers). Ralph H. Stern is often cited by papers focused on Pharmacogenetics and Drug Metabolism (7 papers), Lipoproteins and Cardiovascular Health (6 papers) and Drug Transport and Resistance Mechanisms (6 papers). Ralph H. Stern collaborates with scholars based in United States, Canada and Israel. Ralph H. Stern's co-authors include Pieter C. Wensink, J. Peter Gergen, Reidar F. Sognnaes, Stephen C. Olson, Bingbing Yang, J. David Spence, Robert Abel, H. Rasmussen, Paul H. Siedlik and Anwar Parbtani and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and IEEE Transactions on Automatic Control.

In The Last Decade

Ralph H. Stern

39 papers receiving 1.4k citations

Peers

Ralph H. Stern
Lei Gong China
Ralph H. Stern
Citations per year, relative to Ralph H. Stern Ralph H. Stern (= 1×) peers Lei Gong

Countries citing papers authored by Ralph H. Stern

Since Specialization
Citations

This map shows the geographic impact of Ralph H. Stern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph H. Stern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph H. Stern more than expected).

Fields of papers citing papers by Ralph H. Stern

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph H. Stern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph H. Stern. The network helps show where Ralph H. Stern may publish in the future.

Co-authorship network of co-authors of Ralph H. Stern

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph H. Stern. A scholar is included among the top collaborators of Ralph H. Stern based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph H. Stern. Ralph H. Stern is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McDonnell, Kevin, Joseph A. Chemler, Phillip L. Bartels, et al.. (2018). A human MUTYH variant linking colonic polyposis to redox degradation of the [4Fe4S]2+ cluster. Nature Chemistry. 10(8). 873–880. 20 indexed citations
2.
Coe, Richard, et al.. (2012). MSC training in research methods support. 3 indexed citations
3.
Regalado, Ellen S., Sarah Medrek, Van Tran‐Fadulu, et al.. (2011). Autosomal dominant inheritance of a predisposition to thoracic aortic aneurysms and dissections and intracranial saccular aneurysms. American Journal of Medical Genetics Part A. 155(9). 2125–2130. 35 indexed citations
4.
Stern, Ralph H.. (2008). Nocebo Responses to Antihypertensive Medications. Journal of Clinical Hypertension. 10(9). 723–725. 5 indexed citations
5.
Stern, Ralph H.. (2008). Evaluating New Cardiovascular Risk Factors for Risk Stratification. Journal of Clinical Hypertension. 10(6). 485–488. 11 indexed citations
6.
Stern, Ralph H.. (2007). The role of nicotinic acid metabolites in flushing and hepatotoxicity. Journal of clinical lipidology. 1(3). 191–193. 18 indexed citations
7.
Sahi, Jasminder, Ralph H. Stern, Mark A. Milad, et al.. (2004). EFFECTS OF AVASIMIBE ON CYTOCHROME P450 2C9 EXPRESSION IN VITRO AND IN VIVO. Drug Metabolism and Disposition. 32(12). 1370–1376. 19 indexed citations
8.
Stern, Ralph H., F Chanoine, & Kay A. Criswell. (2003). Are Coagulation Times Biomarkers? Data from a Phase I Study of the Oral Thrombin Inhibitor LB‐30057 (CI‐1028). The Journal of Clinical Pharmacology. 43(2). 118–121. 3 indexed citations
9.
Sahi, Jasminder, Mark A. Milad, Xianxian Zheng, et al.. (2003). Avasimibe Induces CYP3A4 and Multiple Drug Resistance Protein 1 Gene Expression through Activation of the Pregnane X Receptor. Journal of Pharmacology and Experimental Therapeutics. 306(3). 1027–1034. 55 indexed citations
10.
Loi, Cho‐Ming, et al.. (1999). Effect of Troglitazone on the Pharmacokinetics of an Oral Contraceptive Agent. The Journal of Clinical Pharmacology. 39(4). 410–417. 28 indexed citations
11.
Loi, Cho‐Ming, Ralph H. Stern, Edward J. Randinitis, et al.. (1998). Effect of Troglitazone on Steady‐State Pharmacokinetics of Digoxin. The Journal of Clinical Pharmacology. 38(2). 178–183. 13 indexed citations
12.
Stern, Ralph H., et al.. (1998). Atorvastatin does not Produce a Clinically Significant Effect on the Pharmacokinetics of Terfenadine. The Journal of Clinical Pharmacology. 38(8). 753–757. 13 indexed citations
13.
Stern, Ralph H. & Robert Abel. (1997). Rate of Low‐Density Lipoprotein Cholesterol and Apolipoprotein B Changes on Initiation and Discontinuation of Atorvastatin Treatment. The Journal of Clinical Pharmacology. 37(4). 291–296. 6 indexed citations
14.
Stern, Ralph H., et al.. (1997). Atorvastatin Does Not Alter the Anticoagulant Activity of Warfarin. The Journal of Clinical Pharmacology. 37(11). 1062–1064. 35 indexed citations
15.
Stern, Ralph H. & H. Rasmussen. (1996). Left ventricular ejection: Model solution by collocation, an approximate analytical method. Computers in Biology and Medicine. 26(3). 255–261. 44 indexed citations
16.
Fine, JD, C. M. Suchindran, Virginia P. Sybert, et al.. (1994). The National Epidermolysis Bullosa (EB) Registry — Differences in frequencies of selected gastrointestinal manifestations and cancers across major disease types. Journal of Investigative Dermatology. 103(6). 846. 2 indexed citations
17.
Stern, Ralph H., David J. Freeman, & J. David Spence. (1992). Differences in metabolism of time-release and unmodified nicotinic acid: Explanation of the differences in hypolipidemic action?. Metabolism. 41(8). 879–881. 32 indexed citations
18.
Stern, Ralph H., J. David Spence, David J. Freeman, & Anwar Parbtani. (1991). Tolerance to nicotinic acid flushing. Clinical Pharmacology & Therapeutics. 50(1). 66–70. 66 indexed citations
19.
Deeb, S S, Marian C. Cheung, Reiling Peng, et al.. (1991). A mutation in the human apolipoprotein A-I gene. Dominant effect on the level and characteristics of plasma high density lipoproteins. Journal of Biological Chemistry. 266(21). 13654–13660. 68 indexed citations
20.
Stern, Ralph H.. (1974). <title>The Laser In Dentistry</title>. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 40. 111–116. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026